RxDoctor Payments Data

Jolie Chang, MD

Otolaryngology · San Francisco, CANPI 1083856967

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $37,813 of the $51,973 with a category attached, or 72.8%. Inspire Medical Systems, Inc. accounts for 94.8% of it on its own, with 9 other manufacturers making up the rest. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$51,973in general payments, 2019–2025

Across 88 payments — averaging $590.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$49K
  • Livanova USA, Inc.$1K
  • Aerin Medical Inc.$1K
  • Intersect ENT, Inc.$180
  • Carl Zeiss Meditec USA, Inc.$148
  • Medtronic$122
  • plus $239 from 4 others

What the payments were for

  • Consulting fees$37,81373%
  • Speaking & faculty fees$6,79913%
  • Travel & lodging$4,5509%
  • Food & beverage$2,8115%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,973 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$48,717
Medicare patients
139
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$78

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →